Company news
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Class A (SSE:600329) news
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Class A news releases on 6ix. Latest, Sep 25, 2026: "TIANJIN PHARMACEUTICAL DA REN TANG GROUP…
View Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Class A →
Press releases & updates
"TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED"Indicative Announcement on Listing and Transfer of 100% Equity Interest in Shanghai Liuliguang Pharmaceutical Development Co., Ltd. by Shanghai Industrial Investment (Holdings) Co., Ltd. and Shanghai Industrial Investment Development Co., Ltd.
September 24, 2026
"TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED"Notice on Convening the 2nd Extraordinary General Meeting in 2026
September 7, 2026
"TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED"Announcement on Resolutions of the 8th Meeting of the Board of Directors in 2026
September 4, 2026
"TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED"Announcement on Convening the 2026 Semi-annual Performance Briefing and Attending the Online Collective Reception Day for Investors of Listed Companies in Tianjin Jurisdiction
August 26, 2026
"TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED"Semi-annual Report for 2026
August 14, 2026
"TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED"Announcement on Routine Related Party Transactions
August 7, 2026
"TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED"Announcement on Obtaining Drug Registration Certificate by a Branch
August 6, 2026
"TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED"Announcement on Results of Shareholding Increase in S Shares by Controlling Shareholder
August 4, 2026
"TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED"Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
July 31, 2026
"TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED"Indicative Announcement on Convening the 1st Extraordinary General Meeting in 2026
July 27, 2026
"TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED"Notice on Convening the 1st Extraordinary General Meeting in 2026
July 15, 2026
"TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED"Semi-annual Performance Forecast for 2026
July 14, 2026
"TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED"Announcement on Resignation of the Securities Affairs Representative
July 9, 2026
"TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED"Announcement on Implementation of Dividend Distribution for 2025
July 2, 2026
Announcement on Resolutions of the 5th Meeting of the Board of Directors in 2026
June 25, 2026
Announcement on Convening Performance Briefing
June 2, 2026
Indicative Announcement on Shanghai Industrial Investment (Holdings) Co., Ltd. and Shanghai Industrial Investment Development Co., Ltd.'s Proposed Public Solicitation of a Transferee for 100% Equity Interest in Shanghai Liuliguang Pharmaceutical Development Co., Ltd.
May 19, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
May 15, 2026
Indicative Announcement on Convening the 2025 Annual General Meeting
May 11, 2026
Announcement on Evaluation Report on "Corporate Value and Return Enhancement" Action Plan 2025 and "Corporate Value and Return Enhancement" Action Plan 2026
April 29, 2026
Announcement on Adding Provisional Proposal at the 2025 Annual General Meeting
April 16, 2026
Special Report on Deposit and Actual Use of Raised Funds
March 30, 2026
Announcement on Change of Sponsor Representative for Continuous Supervision
March 24, 2026
Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 1% Scale
February 5, 2026
Announcement on Implementation of Quarterly Dividend Distribution for 2025
February 4, 2026
Announcement on Appointment of Senior Management Member
January 28, 2026
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
December 15, 2025
Indicative Announcement on Convening the 2nd Extraordinary General Meeting in 2025
December 9, 2025
Announcement on Branch Obtaining Drug Registration Certificate
November 25, 2025
Announcement on Convening the Q3 2025 Performance Briefing
November 24, 2025
Notice on Convening the 2nd Extraordinary General Meeting in 2025
October 30, 2025
Announcement on Attending 2025 Semi-Annual Report Performance Briefing and Online Collective Reception Day for Investors of Listed Companies in Tianjin Jurisdiction
September 3, 2025
Announcement on Evaluation Report on "Corporate Value and Return Enhancement" Action Plan 2024 and "Corporate Value and Return Enhancement" Action Plan 2025
August 25, 2025
Announcement on Purchasing Liability Insurance for Directors, Supervisors and Senior Management Members
August 14, 2025
Announcement on Cancellation of the Account for Partial Raised Funds
August 13, 2025
Semi-annual Earnings Preannouncement for 2025
July 14, 2025
Announcement on the Company Completing Transfer of 12% Equity of Tianjin TSKF Pharmaceutical Co., Ltd.
June 27, 2025
Announcement on Implementation of Dividend Distribution for 2024
June 26, 2025
Announcement on the Related Transactions with Jinyao Pacific Pharmaceutical Co., Ltd.
June 20, 2025
Announcement on Resolution of the 1st Extraordinary General Meeting in 2025
June 9, 2025
Indicative Announcement on Convening the 1st Extraordinary General Meeting in 2025
June 3, 2025
Announcement on Early Return of Remaining Idle Raised Funds Used to Temporarily Supplement Current Capital
May 29, 2025
Announcement on Resolution of the 2024 Annual General Meeting
May 15, 2025
Indicative Announcement on Convening the 2024 Annual General Meeting
May 11, 2025
Report for Q1 2025
April 29, 2025
Notice on Convening the 1st Extraordinary General Meeting in 2025
April 24, 2025
Announcement on Resolution of the 2nd Meeting of the Board of Directors in 2025
April 15, 2025
Announcement on Estimated Daily Related Party Transactions in 2025
March 30, 2025
Announcement on Audit Institution Changing Project Quality Control Reviewer
February 20, 2025
Annual Earnings Preannouncement for 2024
January 26, 2025